RELEVANCE OF REAL WORLD DATA IN GERMAN AMNOG SUBMISSIONS IN ONCOLOGYVALUE IN HEALTHIF62017-10-010OAAI
THE IMPACT OF PATIENT PREFERENCE STUDIES IN THE GERMAN HEALTHCARE SYSTEMVALUE IN HEALTHIF62017-10-011OAAI
APPLICATION STUDY OF THE EQ-5D-5L IN ONCOLOGY: LINKING SELF REPORTED QUALITY OF LIFE OF PATIENTS WITH METASTATIC COLORECTAL CANCER TO CLINICAL DATA FROM A GERMAN TUMOR REGISTRYVALUE IN HEALTHIF62017-10-010OAAI
UTILIZATION AND EVALUATION OF DELPHI PANELS IN GERMAN AMNOG ASSESSMENTSVALUE IN HEALTHIF62017-10-010OAAI
IMPACT OF TRIAL DESIGN ON PRICE DISCOUNTS AFTER EARLY BENEFIT ASSESSMENT (AMNOG) IN GERMANYVALUE IN HEALTHIF62016-11-011OAAI
PREVALENCE AND INCIDENCE ESTIMATIONS IN GERMAN AMNOG APPLICATIONS - THE ROLE OF REAL-WORLD EVIDENCE (RWE)VALUE IN HEALTHIF62015-11-010OAAI
THE USE OF REAL WORLD EVIDENCE TO SUPPORT MARKET ACCESS OF MEDICAL DEVICES - IMPLICATIONS FOR THE GERMAN SETTINGVALUE IN HEALTHIF62015-11-011OAAI
Evolution of cost structures in rheumatoid arthritis over the past decadeANNALS OF THE RHEUMATIC DISEASESIF20.62015-04-0188OAAI
AMNOG BENEFIT ASSESSMENT FOR ONCOLOGIC AND ORPHAN DRUGS IN GERMANY - IMPLICATIONS FOR PRICE DISCOUNTSVALUE IN HEALTHIF62014-11-011OAAI
COST-EFFECTIVENESS ANALYSIS OF COFFEE CONSUMPTION FOR PREVENTION OF ALL-CAUSE MORTALITY IN GERMANYVALUE IN HEALTHIF62014-11-010OAAI
UTILIZATION PATTERNS FOR TREATMENT WITH STRONG OPIOIDS FOR CHRONIC BACK PAIN IN GERMANYVALUE IN HEALTHIF62013-11-010PREAI
Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: An online IBD registryJOURNAL OF CROHNS & COLITISIF8.72013-06-0176PRE
The role of biosimilars in the treatment of rheumatic diseasesANNALS OF THE RHEUMATIC DISEASESIF20.62013-03-01144OA
DATA ANALYSES ON PREVALENCE AND TREATMENT OF ACUTE MYELOID LEUKAEMIA IN GERMANYVALUE IN HEALTHIF62012-11-010OAAI
ASSESSMENT OF PATIENT SATISFACTION WITH CHRONIC TREATMENT USING THE EUROPEAN PATIENT SURVEY IN ATRIAL FIBRILLATION (EUPS-AF)VALUE IN HEALTHIF62012-11-010OAAI
OUT-OF-POCKET FINANCIAL BURDEN IN ATRIAL FIBRILLATION AND POTENTIAL IMPACT ON CARE: COMPARISON ACROSS FIVE EUROPEAN COUNTRIES USING THE EUROPEAN PATIENT SURVEY IN ATRIAL FIBRILLATION (EUPS-AF)VALUE IN HEALTHIF62012-11-010OAAI
Cost-effectiveness of primary HPV screening for cervical cancer in Germany - a decision analysisEUROPEAN JOURNAL OF CANCERIF7.12011-07-0133PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向